NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.59% | -30.44% | 1,964.47% | -118.01% | 369.53% |
| Total Depreciation and Amortization | -2.53% | 6.67% | 146.91% | -305.37% | -3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.61% | -27.78% | -102.84% | 1,033.63% | -313.21% |
| Change in Net Operating Assets | -101.82% | 182.78% | 5.37% | -66.41% | -144.78% |
| Cash from Operations | -14.94% | 205.98% | 42.85% | 86.75% | -87.63% |
| Capital Expenditure | 98.55% | -687.76% | -15.05% | -267.86% | 75.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.86% | -103.73% | 76.09% | -184.76% | 32.69% |
| Cash from Investing | 85.26% | -311.41% | 66.70% | -191.55% | 40.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.29% | 0.00% | -9.68% | -16.98% | -9.96% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.43% | -1,121.30% | 68.41% | -200.83% | 91.46% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.75% | -553.96% | 34.59% | -3,345.45% | 100.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.75% | 30.21% | 233.33% | -486.38% | -92.16% |